Treatment group | Interaction value | P |
150 MBq/kg 177Lu-lilotomab + rituximab | 0.88 (0.30–2.63) | 0.85 |
350 MBq/kg 177Lu-lilotomab + rituximab | 0.83 (0.22–3.15) | 0.82 |
Endpoint is tumor diameter larger than 20 mm. Data in parentheses are 90% confidence intervals.